Genaissance Pharmaceuticals (MM) 뉴스 - GNSC | 주식 나스닥

개인 투자자를 위한 전문가급 도구.

Genaissance and ParAllele BioScience Sign License and Co-Marketing Agreement

Genaissance and ParAllele BioScience Sign License and Co-Marketing Agreement - Focusing on More Efficient Clinical Trials - NEW HAVEN, Conn., and...

Genaissance Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference

Genaissance Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference NEW HAVEN, Conn...

Genaissance Comments on FDA Guidance on Pharmacogenomics

Genaissance Comments on FDA Guidance on Pharmacogenomics - Guidance Removes Regulatory Uncertainty and Encourages Broader Adoption...

Genaissance Allowed Patent for Method of Testing Individuals for Genetic Predisposition to Reduced Metabolism of Drugs

Genaissance Allowed Patent for Method of Testing Individuals for Genetic Predisposition to Reduced Metabolism of Drugs Ability to Metabolize...

Genaissance and Monsanto Company Team Up with the USDA to Map Soybean Genome

Genaissance and Monsanto Company Team Up with the USDA to Map Soybean Genome - Aim is to Improve Soybeans - NEW HAVEN, Conn., and ST. LOUIS...

Genaissance Pharmaceuticals' New DNA Test - FAMILION(TM) - Becoming Key Tool for Detecting Long QT Syndrome, a Potentially Fatal

Genaissance Pharmaceuticals' New DNA Test - FAMILION(TM) - Becoming Key Tool for Detecting Long QT Syndrome, a Potentially Fatal Cardiac Disorder...

Genaissance Pharmaceuticals Reports 2004 Results

Genaissance Pharmaceuticals Reports 2004 Results Revenue Up 67 Percent; FAMILION(TM) Test Posts Strong Performance; New Gene Markers Discovered;...

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its Fourth Quarter 2004 Conference Call

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its Fourth Quarter 2004 Conference Call NEW HAVEN, Conn., Feb. 3...

Genaissance Obtains License to Vanderbilt Patent Linking Genetics to Key Drug Safety Issue

Genaissance Obtains License to Vanderbilt Patent Linking Genetics to Key Drug Safety Issue - Method helps identify experimental drugs that may...

Genaissance Study Sheds Light on Mechanism of Heart Disease Risk by Linking Genetic Variation to the Effect of Hormone Replaceme

Genaissance Study Sheds Light on Mechanism of Heart Disease Risk by Linking Genetic Variation to the Effect of Hormone Replacement Therapy...

Thanks. I don't own any. Just curious about the company. I've been waiting for them to take the next step to legitimize their science but it hasn't been forthcoming. Still waiting.

FYI - a prospectus came out that shows deteriorating financials. So be careful! Good luck.

http://www.shareholder.com/GNSC/EdgarDetail.cfm?CompanyID=GNSC&CIK=1110009&FID=1047469-05-15...

👍️0

gator16 20 년 전

I own a lot of GNSC..maybe too much..I keep hearing great things are coming though....guess I will have to wait a while !
98000 shrs at $3.26 groan !!

👍️0

DougS. 20 년 전

Anyone out there follow this company besides me???

👍️0

gator16 20 년 전

Welcome everyone to this new board. This company is the future !!

👍️0

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Genaissance Pharmaceuticals (MM) (GNSC)

개인 투자자를 위한 전문가급 도구.

GNSC 뉴스

Genaissance and ParAllele BioScience Sign License and Co-Marketing Agreement

Genaissance Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference

Genaissance Comments on FDA Guidance on Pharmacogenomics

Genaissance Allowed Patent for Method of Testing Individuals for Genetic Predisposition to Reduced Metabolism of Drugs

Genaissance and Monsanto Company Team Up with the USDA to Map Soybean Genome

Genaissance Pharmaceuticals' New DNA Test - FAMILION(TM) - Becoming Key Tool for Detecting Long QT Syndrome, a Potentially Fatal

Genaissance Pharmaceuticals Reports 2004 Results

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its Fourth Quarter 2004 Conference Call

Genaissance Obtains License to Vanderbilt Patent Linking Genetics to Key Drug Safety Issue

Genaissance Study Sheds Light on Mechanism of Heart Disease Risk by Linking Genetic Variation to the Effect of Hormone Replaceme

Genaissance Allowed Patent for Novel Methods to Correlate Genetics With Drug Safety and Efficacy

Genaissance Identifies Genetic Markers Implicated in Fatal Side Effects Of Schizophrenia Drug

Genaissance Pharmaceuticals Signs Research Agreement With Sygen International

Genaissance to Raise Approximately $6 Million in Private Placement

GNSC Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

시장 데이터

뉴스

도구

시장

팔로우

Hot Features

피드 팔로우

실시간 옵션 플로우

모니터

Genaissance Pharmaceuticals (MM) (GNSC) 뉴스

Genaissance Pharmaceuticals (MM) (GNSC)

개인 투자자를 위한 전문가급 도구.

GNSC 뉴스

Genaissance and ParAllele BioScience Sign License and Co-Marketing Agreement

Genaissance Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference

Genaissance Comments on FDA Guidance on Pharmacogenomics

Genaissance Allowed Patent for Method of Testing Individuals for Genetic Predisposition to Reduced Metabolism of Drugs

Genaissance and Monsanto Company Team Up with the USDA to Map Soybean Genome

Genaissance Pharmaceuticals' New DNA Test - FAMILION(TM) - Becoming Key Tool for Detecting Long QT Syndrome, a Potentially Fatal

Genaissance Pharmaceuticals Reports 2004 Results

Genaissance Pharmaceuticals, Inc. Invites You to Participate in its Fourth Quarter 2004 Conference Call

Genaissance Obtains License to Vanderbilt Patent Linking Genetics to Key Drug Safety Issue

Genaissance Study Sheds Light on Mechanism of Heart Disease Risk by Linking Genetic Variation to the Effect of Hormone Replaceme

Genaissance Allowed Patent for Novel Methods to Correlate Genetics With Drug Safety and Efficacy

Genaissance Identifies Genetic Markers Implicated in Fatal Side Effects Of Schizophrenia Drug

Genaissance Pharmaceuticals Signs Research Agreement With Sygen International

Genaissance to Raise Approximately $6 Million in Private Placement

GNSC Discussion

최근 히스토리

회사 소개

사업

Popular

앱 받기

광고 제거